The present invention relates to methods and compositions for monitoring, diagnosis, prognosis, and determination of treatment regimens in subjects suffering from or suspected of having a
renal injury. In particular, the invention relates to using a one or more assays configured to detect a
kidney injury marker selected from the group consisting of
Coagulation factor VII, CA 19-9,
Insulin-like
growth factor-
binding protein 7, C-X-C motif
chemokine 6, and C-C motif
chemokine 13 as diagnostic and prognostic biomarkers in renal injuries.